Lupus Trial, Recruiting NCT07148115 Sponsor: University of Algiers Condition: Lupus
Back to Lupus

Lupus Trial, Recruiting

NCT07148115
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The person is a woman of childbearing age who has been pregnant at least once
  • At least one pregnancy happened before being diagnosed with lupus (LES)
  • The lupus (LES) diagnosis was made after at least one pregnancy had already occurred
  • The lupus (LES) diagnosis meets specific classification standards known as either the 1997 ACR criteria or the EULAR 2019 criteria (confirm with trial site)

Who may not be able to join:

  • People who received a lupus (LES) diagnosis before ever becoming pregnant for the first time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Wafia-Nadia Nibouche-Hattab, Professor of medicine, University of Algiers. Faculty of medicine

Phone: +213-771-810-932

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Algiers
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2025

Where this trial is recruiting

Algeria

Primary endpoints

1. Primary outcome: Prevalence of obstetrical events before the diagnosis of SLE. Secondary outcome: 1. Assess the severity of the disease at the time of LES diagnosis. 2. Compare the outcomes of pregnancies before and after the LES

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov